USE OF METHYLATED OR UNMETHYLATED LINE-1 DNA AS A CANCER MARKER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090068660A1
SERIAL NO

12110264

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a method of detecting LINE-1 (long interspersed nucleotide elements-1) DNA either methylated or unmethylated at the promoter region in a tissue or body fluid sample from a subject. Also disclosed are methods of using LINE-1 DNA as a biomarker for diagnosing, predicting, and monitoring cancer progression and treatment.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JOHN WAYNE CANCER INSTITUTE2200 SANTA MONICA BOULEVARD ST JOHN SOUTH HEALTH CENTER SANTA MONICA CA 90404

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hoon, Dave SB Los Angeles, US 48 292
Sunami, Eiji Tokyo, JP 8 95

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation